Crisafulli, S. Et Al. 2023. An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting. EXPERT OPINION ON DRUG SAFETY , vol.1 , 1-17.

Crisafulli, S., Khan, Z., Karataş, Y., Tuccori, M., & Trifiro, G., (2023). An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting. EXPERT OPINION ON DRUG SAFETY , vol.1, 1-17.

Crisafulli, Salvatore Et Al. "An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting," EXPERT OPINION ON DRUG SAFETY , vol.1, 1-17, 2023

Crisafulli, Salvatore Et Al. "An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting." EXPERT OPINION ON DRUG SAFETY , vol.1, pp.1-17, 2023

Crisafulli, S. Et Al. (2023) . "An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting." EXPERT OPINION ON DRUG SAFETY , vol.1, pp.1-17.

@article{article, author={Salvatore Crisafulli Et Al. }, title={An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting}, journal={EXPERT OPINION ON DRUG SAFETY}, year=2023, pages={1-17} }